Phys-Org Medical Xpress prostate cancer 'Golden Era

In summary: They have made significant and sustained investments over the past few years in R&D on new ways to treat prostate cancer, and the results of this trial are going to contribute to that effort.
  • #1
phys-hack
1
0
Phys-Org Medical Xpress prostate cancer 'Golden Era"

The article "Golden age of prostate cancer treatment hailed as fourth drug in two years extends life" has attracted my attention, just a few weeks following my surgery for prostate cancer. Because the study tracks cancer that has metastasized from prostate cancer to more lethal forms of remotely located prostate cancer, I am interested in the study.

This "Golden Age" that has been "hailed" is the report of lengthening the survival of patients from 1 to 1.5 years. Six months of added life (more accurately quoted as 'survival', not as any quality of life) is 'hailed'?. This is a Golden Age?

Six months added life is Physorg's definition of a 'Golden Age'?

Of course, it is not.

There needs to be some mechanism in place that responsibly evaluates PR news releases, instead of simple parroting their content, at the breathless level of PR agents, as opposed to direct interviews of the scientists responsible for the submission to the peer-reviewed scientific literature.

Since PhysOrg makes itself available to unsophisticated readers, it has an essential responsibility to evaluate the source(s) of information reported, and an honest (peer-reviewed) evaluation of the contents that PhysOrg reports.

When self-interest reports are implicitly rubber-stamped as 'facts', we are all poorer for experience.
 
Biology news on Phys.org
  • #3


Additional info at Medscape http://www.medscape.com/viewarticle/769167 I deal largely in radiation therapy, but a few things to note. Local, regional, and distant control, as well as pain relief are significant objectives for any patients. While this isn't a cure, slowing the process and improving the quality of life are still very positive advances. The US FDA has given a "Priority Review designation" to this drug, and the Phase III trials are not indicators of a rubber stamp. Additionally, being able to demonstrate the effectiveness sufficiently to be able to stop the trial and get the Priority Review designation for the drug isn't done lightly. MSKCC and the other institutions involved in the trials are very creditable.
 

FAQ: Phys-Org Medical Xpress prostate cancer 'Golden Era

What is "Phys-Org Medical Xpress prostate cancer 'Golden Era"?

"Phys-Org Medical Xpress prostate cancer 'Golden Era" is a term used to describe the current state of research and advancements in the field of prostate cancer. It refers to a period of time where there have been significant breakthroughs and developments in the understanding and treatment of this type of cancer.

What are some of the recent advancements in prostate cancer research?

Some of the recent advancements in prostate cancer research include the development of new and more effective treatments, such as targeted therapies and immunotherapies. There has also been progress in understanding the genetic and molecular basis of prostate cancer, which has led to the identification of potential biomarkers and new drug targets.

How has the "Golden Era" impacted prostate cancer survival rates?

The "Golden Era" has had a significant impact on prostate cancer survival rates. With the development of new treatments and improved understanding of the disease, the overall survival rate for prostate cancer has increased. Additionally, there has been a decrease in mortality rates, as well as an increase in the number of men living with the disease as a chronic condition.

Are there any potential risks or limitations associated with the advancements in prostate cancer research?

As with any medical treatment, there are potential risks and limitations associated with the advancements in prostate cancer research. These may include side effects from treatments, as well as the cost and accessibility of new therapies. It is important for patients to discuss these factors with their healthcare providers to make informed decisions about their treatment options.

What does the future hold for prostate cancer research?

The future of prostate cancer research looks promising, with continued advancements in understanding the disease and developing new treatments. There is also ongoing research into prevention and early detection methods. It is hoped that these efforts will lead to improved outcomes and ultimately a cure for prostate cancer.

Similar threads

Medical FDA antidepressant warnings of suicide risk among kids may have the opposite effect
Replies
0
Views
61
Medical Malpractice: A Case of Deception and Tragedy
Replies
6
Views
3K
News Does 'pack journalism' shape the science news we read?
Replies
15
Views
2K
News Bush Honest & Trustworthy Until How Many Lies?
2
Replies
65
Views
9K

Hot Threads

Recent Insights

Back
Top